Abstract
This paper reviews our current understanding of age-related meibomian gland dysfunction (MGD) and the role of the nuclear receptor, peroxisome proliferatoractivated receptor gamma (PPARγ), in the regulation of meibomian gland function, meibocyte differentiation and lipid synthesis. The studies suggest that PPARγ is a master regulator of meibocyte differentiation and function, whose expression and nuclear signaling coupled with meibocyte renewal is altered during aging, potentially leading to atrophy of the meibomian gland as seen in clinical MGD. Study of meibomian gland stem cells also suggest that there is a limited number of precursor meibocytes that provide progeny to the acini, that may be susceptible to exhaustion as occurs during aging and other environmental factors. Further study of pathways regulating PPARγ expression and function as well as meibocyte stem cell maintenance may provide clues to establishing cellular and molecular mechanisms underlying MGD and the development of novel therapeutic strategies to treating this disease.
Introduction
Meibomian glands are holocrine, sebaceous-like glands in the upper and lower eyelid that excrete lipid (meibum) onto the surface of the eye to form the lipid layer of the tear film that reduces tear evaporation (Mishima and Maurice, 1961; Nicolaides et al., 1981) . Dysfunction of the meibomian glands (MGD) as assessed by gland dropout and meibum quality, is a common eyelid disorder having widespread prevalence in the US population with the incidence increasing with age (Hom et al., 1990; Lemp and Nichols, 2009; Ong, 1996; Ong and Larke, 1990) . MGD is also thought to be a major cause of evaporative dry eye disease (EDED) (Mathers and Lane, 1998) , with loss of glands and/or altered meibum resulting in decreased tear film lipid, increased aqueous tear evaporation (Mishima and Maurice, 1961) , and increased tear film osmolarity (Gilbard et al., 1989) ; leading to ocular surface changes, unstable tear film and blepharitis (McCulley and Shine, 2003; Shimazaki et al., 1995) .
The proposed pathogenic mechanism underlying the most common form of MGD is thought to involve obstruction of the meibomian gland by hyperkeratinization of the ductal epithelium leading to blockage of the meibomian gland orifice, stasis of the gland, cystic dilatation and then atrophy of the holocrine, excretory acini (Foulks and Bron, 2003; Knop et al., 2011) . Recent studies from our laboratory suggest that alternative pathways involving aging and stem cell exhaustion mediated by environmental stress may also play important roles in the development of meibomian gland dropout and altered meibum secretion. In this review article, we will present our latest understanding of the effects of aging, environmental stress and stem cell renewal on meibomian gland function with the goal of rethinking the pathogenesis of MGD and EDED as well as propose new treatments based on these new concepts.
Effects of Age on Human Meibomian Glands
Aging has long been recognized as a contributing factor to the development of MGD (Hom et al., 1990; Hykin and Bron, 1992) . While past work has primarily focused on the effects of hormones in contributing to these changes (Sullivan et al., 2006; Sullivan et al., 2002) , little is known about how aging effects acinar meibocyte differentiation, lipid synthesis and function. In a study using excess surgical eyelid tissue from patients ranging in age from 18-95 years, we identified altered expression of the lipid sensitive, nuclear receptor, peroxisome proliferator-activated receptor gamma (PPARγ) . PPARγ is a member of closely homologous genes ubiquitously expressed in various tissues, and is the major subtype expressed in adipocytes and sebocytes, where it regulates the expression of genes involved in lipogenesis (Rosen et al., 1999; Rosen and Spiegelman, 2001 ). Using immunocytochemistry, PPARγ appears to be highly expressed in meibomian gland acinar cells/meibocytes, showing a distinct cytoplasmic and nuclear localization in tissue samples from youngest patients (ages, 18 and 44 years) ( Figure 1A ). Interestingly, older individuals (>60 years) showed predominantly nuclear staining, with cytoplasmic staining limited to the basal acinar cells in 17 of 31 subjects ( Figure 1B ). Using antibodies against the nuclear antigen, Ki67 that labels actively cycling cells (Petroll et al., 1998) , the number of positively stained basal acinar cells were significantly higher in meibomian glands from the younger compared with older subjects based on linear regression analysis (r 2 =0.35; P<.001) ( Figure 1C and 1D ). Together, these results indicate that aging human meibomian glands show both decreased meibocyte differentiation as identified by decreased and altered PPARγ expression and decreased meibocyte cell renewal as identified by Ki67 staining. These two findings suggest that the development of age-related MGD may involve altered PPARγ signaling and/or loss of stem cell renewal leading to acinar atrophy and development of an age-related MGD.
Mouse as a Model for Age-Related MGD
During development mouse meibomian gland morphogenesis begins after eyelid fusion with the formation of regularly spaced epithelial placodes within the fused epithelium at embryonic day 18.5, which is followed by invasion of the epithelium into the underlying mesenchyme to form the presumptive meibomian gland duct (Nien et al., 2010 (Fuchs, 2007) , and that PPARγ may play an important role in meibomian gland morphogenesis, function and meibocyte differentiation, with expression of PPARγ preceding formation of meibomian gland acini.
As the adult mouse ages, changes in PPARγ expression and meibocyte renewal in the meibomian gland that parallel changes seen in human meibomian glands are also detected (Nien et al., 2009) . In evaluating eyelid tissue obtained from C57Bl/6 mice at 2, suggesting an age-related gland atrophy.
Age-related changes in PPARγ receptor signaling have also been studied by western blotting . When meibomian gland tissue extracts from young mice (2 months old) were separated into the cytoplasmic and nuclear fraction and probed for PPARγ expression, the cytoplasmic fraction contained both the 50 kD native protein and 72 kD post translationally modified protein, while the nuclear fraction contained only the 50 kD isoform. By comparison, meibomian gland extracts from old mice (2 years old) showed a significant 100% loss of the 50 kD, a significant 75% loss of 72 kD cytoplasmic PPARγ (P<.05), and a significant 40% decrease in the 50 kD nuclear PPARγ (P<.05). Together these finding confirm the immunocytochemical findings and show that the PPARγ receptor is significantly down-regulated with age, suggesting a significant loss of lipid synthesis.
Overall, these findings indicate that there is altered PPARγ receptor signaling in older mice that parallel changes in meibocyte renewal and lipid synthesis that is associated with age-related MGD in humans. Furthermore, the similarity in the agerelated findings for human and mouse suggest that the mouse model may be a valuable tool in understanding the effects of age on meibomian gland function, as well as identifying the underlying mechanism of age-related MGD.
Absence of ductal hyper-keratinization in Mouse age-related MGD
Because age-related MGD in the mouse and human both lead to acinar atrophy and loss of the meibomian glands, we have investigated the role of hyperkeratinization in the development of age-related MGD in mouse as hyperkeratinization is putatively the most common pathway leading to acinar atrophy and meibomian gland dropout (Foulks and Bron, 2003; Knop et al., 2011) . For a part of these studies we have developed a novel imaging approach, Immunofluorescent Computed Tomography (ICT), to localize and quantify multiple biomarkers of cell differentiation and function in large tissue volumes at high resolution (Parfitt et al., 2012) . ICT uses computer reconstruction of serial sectioned and sequentially immunostained butyl-methyl methacrylate (BMMA) embedded tissue ( Figure 3 ). Using ICT we have 3-dimensionally reconstructed the murine lower eyelid that contains the meibomian gland and localized cell nuclei (DAPI), Ki67 and cytokeratin (CK) 1, 5 and 6 to assess cell density, cell proliferation, gland keratinisation and gland volume.
In reconstructions of 5-month and 2-year old mouse eyelids, we detected a dramatic decrease in gland size, combined with a loss of ductal, acinar and lipid volume in old meibomian glands Parfitt et al., 2013) . Using immunocytochemistry to localize cytokeratin biomarkers for keratinization (CK1) and non-keratinized stratified epithelium (CK6) (Figure 4 ), we detected extension of CK1 from the skin epidermis into the orifice of the meibomian gland in young mice, with continued immunostaining posterior to the orifice where it abruptly stopped at the mucocutaneous junction (MCJ) and was replaced by CK6 stained conjunctival epithelium. CK1 staining also abruptly stopped at the orifice of the gland, where it was replaced again by CK6 stained meibomian gland ductal epithelium. In old mouse meibomian glands, CK1 staining from the skin epidermis extended up to the anterior border of the orifice, but did not extend posteriorly, indicating that the MCJ had been displaced anteriorly, and that the lid margin was less, not more, keratinized. CK1 staining also did not appear to extend any deeper into the duct of the gland.
Interestingly, epithelial plugs were detected in old meibomian glands, but these plugs were comprised of CK5 and CK6 immunostained epithelial cells, not CK1.
Overall, these findings support the premise that hyperkeratinization leading to gland obstruction does not play a role in the development of age-related MGD in the mouse. Additionally, the anterior displacement of the MCJ in old mouse eyelids appears to mimic the anterior displacement of the MCJ, clinically identified as Marx line, observed in aging humans (Bron et al., 2011a, b; Yamaguchi et al., 2006) . Since there is a strong correlation between the anterior displacement of the MCJ and the development of clinical MGD (Yamaguchi et al., 2006) , these findings also bring into question the role of hyperkeratinization in the development of human MGD .
To further evaluate the role of keratinisation in meibomian gland function we have identified the gene expression patterns of young and old mouse meibomian glands by performing a transcriptome analysis using RNA sequencing (Parfitt et al., 2016a) .
The results of differential gene expression data indicated that 18 genes were 2 fold enriched in meibomian glands of young male and female mice while 151 genes were enriched in old meibomian glands. Of genes showing significant differences, a number of pathways were identified by GO ontology involving genes known to be associated with PPARγ function that were decreased in old tissue. Of particular interest was the finding that there was no significant difference in the expression of keratinisation genes, including CK 1 and CK10 as well as cornified envelope proteins, Sprr1a and Sprr2a, that are necessary for keratinization. Together, these findings support our immunocytochemical and biochemical findings indicating that PPARγ signaling is significantly altered in age-related MGD, and that obstruction due to hyperkeratinization plays little, if any, role.
PPARγ Control of Mouse Meibocyte Differentiation
To begin to understand the role of PPARγ in regulating meibomian gland function, we developed an immortalized mouse meibocyte cell line using a SV40 lentiviral vector . Lipid synthesizing clones were tested for effects of PPAR agonist, 
Effect of Desiccating Stress on Mouse Meibomian Gland Function
Over the past decade a mouse model of low humidity environmental stress has become widely popular for assessing the underlying mechanism of ocular surface inflammation associated with dry eye (Stern et al., 1998a, b) . While studies have focused on changes in the conjunctival and corneal ocular surface, we have recently evaluated the changes in the meibomian gland of mice exposed to this environmental stress (Suhalim et al., 2014) . In our study, low humidity stress caused a 3-fold increase in basal acinar cell proliferation from 18.3 ±11.1% in untreated mice to 64.4 ± 19.9% and 66.6 ± 13.4% after 5 and 10 days exposure, respectively (P < .001) ( Figure 5 ).
Since the meibomian gland is a holocrine gland, in which cells undergo differentiation and disintegration to release lipid, the increase proliferation suggests an increase in meibocyte renewal compensatory to the increase disintegration and release of lipid into the meibomian gland duct. This increased release was also suggested by dilation of the duct as shown in Figure 5 . Meibomian glands from mice exposed to desiccating stress showed no decrease from acini to central duct, and in some cases showed increased protein suggesting that increased cell proliferation and cell turnover induced by the environmental stress may lead to abnormal or altered meibocyte differentiation and retention of protein in the lipid prior to secretion from the gland. Retention of protein most likely would have a profound effect on the lipid quality and fluidity. Recent studies assessing the surface pressure of meibomian gland lipids expressed from normal human subjects using a
Lagmuir trough indicate that incorporation of purified keratin proteins into human meibum increased the surface pressure above that of meibum alone (Palaniappan et al., 2013) . The authors postulate that a 10% increase in keratin proteins as reported by
Ong et al for MGD subjects (Ong et al., 1991) would make the lipid more rigid and subject to fracture if incorporated into the lipid layer of the tear film.
These data are consistent with a model that a environmental stress may have a direct effect on meibomian gland function, leading to a significant increase in basal acinar cell proliferation, abnormal meibocyte differentiation, and altered lipid production.
Not only may environmental stress lead to changes in lipid quality, but continual or repeated exposure may potentially effect meibocyte renewal by depleting meibocyte stem cells and lead to early aging changes and gland atrophy.
Meibomian Gland Stem cells
Until recently, the location and characterization of meibomian gland stem cells was controversial with Lavker et al suggesting that stem cells were located along the central duct, similar to the location of hair follicle stem cells along the hair follicle 'bulge' region (Lavker et al., 2003) , and Olami et al suggesting that stem cells were located at the interface between the acinar and ductal basal cells (Olami et al., 2001) . To address this question, we used the H2B-GFP/K5tTA 'tet-off' transgenic mouse to initially label proliferating cells with nuclear GFP and then follow labeled cells after tetracycline treatment to turn-off nuclear GFP expression . ICT was then used to identify, localize and quantify the label retaining cells (LRCs) at different intervals after tetracycline treatment. In our study, there was a rapid loss of GFP labeled cells due to either dilution (continued proliferation to dilute nuclear label) or differentiation and disintegration. By 28 days after tetracycline treatment, there were on average only 25±4 GFP labeled cells within individual meibomian glands, located at the interface between the acini and the ductal epithelium. The number of GFP labeled cells continued to decline over time to 12±2 and 9±3 LRCs at 48 and 56 days after treatment.
with all LRCs observed at the interface between CK6 + ductal epithelium and CK6 -/PPARγ + acinar basal epithelium of the meibomian gland. Additionally, LRCs in the meibomian gland were exclusively SOX9 + and BLIMP1 -, putative sebocyte progenitor markers, however both SOX9 + and BLIMP1 + differentiated ductal and acinar epithelial cells could also be detected. Overall, these data suggest that meibomian gland stem cells are located at the interface between the ductal and acinar basal epithelium
Since meibocytes rapidly transit through the acinus, migrating from the basal compartment to the disintegrating compartment within 9 days (Olami et al., 2001) , continuous basal meibocyte renewal is critical to normal meibomian gland function. To begin to understand this process we have used lineage tracing to better assess the origin and number of stem cell that participate in this process (Parfitt et al., 2016b) . For these studies we have used K14CreER T2 -Confetti mouse, which express the conditional Since acinar stem cells are localized to sites of individual acini, it is possible that exhaustion of these stem cells lead to loss of individual acini, and meibomian gland dropout as seen in clinical MGD.
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New pathogenesis of meibomian gland dysfunction
The most commonly recognized mechanism for the development of MGD has been a 'ductal centric' hypothesis involving epithelial hyperkeratinization causing obstruction of meibomian orifice, stasis of meibum, and cystic dilation of the duct that leads to a secondary, disuse acinar atrophy and gland dropout (Knop et al., 2011) Since these changes appear to occur in the absence of hyperkeratinization and ductal dilation, it is not likely that the observed changes in PPARγ signaling are the result of a 'disuse atrophy' as proposed for obstructive MGD. Rather, it is more likely that factors regulating PPARγ receptor expression and function play the central role.
Unfortunately, little is known regarding the molecular pathways controlling PPARγ-regulated meibocyte differentiation. Some possible factors that may influence this pathway are presented in Figure 7 . In particular aging and undefined age-related factors may clearly play a role, since our experimental findings are common in older individuals and animals. Additionally, increased tear evaporation associated with low humidity and increased airflow also leads to increased meibocyte proliferation, differentiation and altered lipid synthesis, suggesting that a range of environmental stress responses may effect meibocyte differentiation, including contact lens wear, long known to cause MGD (Henriquez and Korb, 1981; Korb and Henriquez, 1980) , prolonged blinking intervals associated with video display terminal usage and reading (Fenga et al., 2008) , and low humidity environments (McCulley et al., 2006) . Hormonal factors are also known to be associated with ocular surface disease and thought to be involved in the development of MGD (Sullivan et al., 2006; Sullivan et al., 2002) .
Dietary factors also influence meibomian gland differentiation, as recently shown in the Hairless mouse fed on a limited lipid diet contain low amounts of lipids known to be PPARγ agonists (Miyake et al., 2016) . Neurogenic factors, while little studied, are likely to play an important role since the meibomian gland is highly innervated, unlike their counterpart, the sebaceous gland (Kam and Sullivan, 2011; Kirch et al., 1996) . Finally, recent studies indicate that inflammation and allergy may have marked effects on meibomian gland function leading to plugging, ductal dilation and gland hypertrophy (Reyes and Saban, 2016) . that little is known of the effect of inflammation and inflamma A second pathway leading to altered meibocyte function is suggested by the finding of a limited number of meibomian gland LRC, suggesting a limited stem cell population. The additional finding that acini are renewed by a single stem cell adjacent to individual acini, further suggest that stem cell exhaustion or depletion may play an important role in the loss of acini due to age. Our finding that environmental factors may influence the proliferative rate of meibocytes, also suggest that early stem cell depletion may underlie meibomian gland dropout and acinar atrophy in younger individuals. There are only a handful of studies that have evaluated meibomian gland stem cells, and little is known about control of meibomian gland stem cell fate and survival. Nevertheless, similar factors influencing meibocyte differentiation as presented in Figure 7 , may also play a role in stem cell maintenance as discussed above.
Future Direction and Therapeutic Strategies
Clearly, a better understanding of the cellular and molecular pathways regulating meibomian gland function and meibocyte differentiation are needed to help establish a clearer mechanistic foundation for the development and progression of MGD. The recent establishment of a telomerized human meibomian gland epithelial cell line will undoubtedly help toward the discovery of some of these pathways .
Additionally, better models of MGD in mice are needed to validate putative pathways and understand the relationship between meibomian gland function, meibocyte differentiation and ocular surface integrity and disease. Such models, both in vitro and in vivo, will also help in the discovery of new therapies that may restore meibomian gland function and/or reverse pathologic changes leading to ocular surface disease.
Some potential targets are suggested by our studies of PPARγ, and include agonist, such as Rosiglitazone or other drugs currently used in diabetes, that stimulate PPARγ receptor signaling and induce lipid synthesis and potentially meibocyte differentiation.
Understanding the effects of upstream regulators of PPARγ and how they influence PPARγ signaling may also lead to the development of new approaches to treating MGD.
Finally, a fuller understanding of meibocyte renewal and the maintenance of meibocyte stem cells may have a dramatic impact on our ability to maintain meibomian gland function in patients that show marked loss of meibomian glands as well as regenerate meibomian glands and acini to replace lost tissue.
